Clinical trial
LAL-BR/2001: Study Treatment to Low Risk ALL
NCT00526175 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- LAL-BR/2001: Study Treatment to Low Risk ALL
- Lead sponsor
- PETHEMA Foundation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2001
- Completion date
- December 31, 2015
- Enrollment
- 150 (estimated)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.
acute lymphoblastic leukemia